T-cell receptor and carbamazepine-induced Stevens–Johnson syndrome and toxic epidermal necrolysis: understanding a hypersensitivity reaction

References

• Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA 279(15), 1200–1205 (1998).
   PubMed Web of Science ®Google Scholar
• Pirmohamed M, Naisbitt DJ, Gordon F, Park BK. The danger hypothesis – potential role in idiosyncratic drug reactions. Toxicology 181–182, 55–63 (2002).
   PubMed Web of Science ®Google Scholar
• Roujeau JC. Clinical heterogeneity of drug hypersensitivity. Toxicology 209(2), 123–129 (2005).
   PubMed Web of Science ®Google Scholar
• Hausmann O, Schnyder B, Pichler WJ. Drug hypersensitivity reactions involving skin. Handb. Exp. Pharmacol. (196), 29–55 (2010).
   PubMedGoogle Scholar
• Chung WH, Hung SI, Hong HS et al. Medical genetics: a marker for Stevens–Johnson syndrome. Nature 428(6982), 486 (2004).
   PubMed Web of Science ®Google Scholar
• Hung SI, Chung WH, Liou LB et al. HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol. Proc. Natl Acad. Sci. USA 102(11), 4134–4139 (2005).
   PubMed Web of Science ®Google Scholar
• Mallal S, Nolan D, Witt C et al. Association between presence of HLA-B*5701, HLA-DR7, and HLA-DQ3 and hypersensitivity to HIV-1 reverse-transcriptase inhibitor abacavir. Lancet 359(9308), 727–732 (2002).
   PubMed Web of Science ®Google Scholar
• McCormack M, Alfirevic A, Bourgeois S et al. HLA-A*3101 and carbamazepine-induced hypersensitivity reactions in Europeans. N. Engl. J. Med. 364(12), 1134–1143 (2011).
   PubMed Web of Science ®Google Scholar
• Chen P, Lin JJ, Lu CS et al.; Taiwan SJS Consortium. Carbamazepine-induced toxic effects and HLA-B*1502 screening in Taiwan. N. Engl. J. Med. 364(12), 1126–1133 (2011).
   PubMed Web of Science ®Google Scholar
• Chessman D, Kostenko L, Lethborg T et al. Human leukocyte antigen class I-restricted activation of CD8+ T cells provides the immunogenetic basis of a systemic drug hypersensitivity. Immunity 28(6), 822–832 (2008).
   PubMed Web of Science ®Google Scholar
• Gomes ER, Demoly P. Epidemiology of hypersensitivity drug reactions. Curr. Opin. Allergy Clin. Immunol. 5(4), 309–316 (2005).
   PubMed Web of Science ®Google Scholar
• Roujeau JC, Stern RS. Severe adverse cutaneous reactions to drugs. N. Engl. J. Med. 331(19), 1272–1285 (1994).
   PubMed Web of Science ®Google Scholar
• Roujeau JC. The spectrum of Stevens–Johnson syndrome and toxic epidermal necrolysis: a clinical classification. J. Invest. Dermatol. 102(6), 28S–30S (1994).
   PubMed Web of Science ®Google Scholar
• Locharernkul C, Loplumlert J, Limotai C et al. Carbamazepine and phenytoin induced Stevens–Johnson syndrome is associated with HLA-B*1502 allele in Thai population. Epilepsia 49(12), 2087–2091 (2008).
   PubMed Web of Science ®Google Scholar
• Man CB, Kwan P, Baum L et al. Association between HLA-B*1502 allele and antiepileptic drug-induced cutaneous reactions in Han Chinese. Epilepsia 48(5), 1015–1018 (2007).
   PubMed Web of Science ®Google Scholar
• Mehta TY, Prajapati LM, Mittal B et al. Association of HLA-B*1502 allele and carbamazepine-induced Stevens–Johnson syndrome among Indians. Indian J. Dermatol. Venereol. Leprol. 75(6), 579–582 (2009).
   PubMed Web of Science ®Google Scholar
• Ozeki T, Mushiroda T, Yowang A et al. Genome-wide association study identifies HLA-A*3101 allele as a genetic risk factor for carbamazepine-induced cutaneous adverse drug reactions in Japanese population. Hum. Mol. Genet. 20(5), 1034–1041 (2011).
   PubMed Web of Science ®Google Scholar
• Britschgi M, von Greyerz S, Burkhart C, Pichler WJ. Molecular aspects of drug recognition by specific T cells. Curr. Drug Targets 4(1), 1–11 (2003).
   PubMed Web of Science ®Google Scholar
• Cribb AE, Nuss CE, Alberts DW et al. Covalent binding of sulfamethoxazole reactive metabolites to human and rat liver subcellular fractions assessed by immunochemical detection. Chem. Res. Toxicol. 9(2), 500–507 (1996).
   PubMed Web of Science ®Google Scholar
• Pichler WJ, Beeler A, Keller M et al. Pharmacological interaction of drugs with immune receptors: the p-i concept. Allergol. Int. 55(1), 17–25 (2006).
   PubMedGoogle Scholar
• Yang CW, Hung SI, Juo CG et al. HLA-B*1502-bound peptides: implications for the pathogenesis of carbamazepine-induced Stevens–Johnson syndrome. J. Allergy Clin. Immunol. 120(4), 870–877 (2007).
   PubMed Web of Science ®Google Scholar
• Naisbitt DJ, Britschgi M, Wong G et al. Hypersensitivity reactions to carbamazepine: characterization of the specificity, phenotype, and cytokine profile of drug-specific T cell clones. Mol. Pharmacol. 63(3), 732–741 (2003).
   PubMed Web of Science ®Google Scholar
• Schmid DA, Depta JP, Pichler WJ. T cell-mediated hypersensitivity to quinolones: mechanisms and cross-reactivity. Clin. Exp. Allergy 36(1), 59–69 (2006).
   PubMed Web of Science ®Google Scholar
• Wu Y, Sanderson JP, Farrell J et al. Activation of T cells by carbamazepine and carbamazepine metabolites. J. Allergy Clin. Immunol. 118(1), 233–241 (2006).
   PubMed Web of Science ®Google Scholar
• Nassif A, Bensussan A, Boumsell L et al. Toxic epidermal necrolysis: effector cells are drug-specific cytotoxic T cells. J. Allergy Clin. Immunol. 114(5), 1209–1215 (2004).
   PubMed Web of Science ®Google Scholar
• Wu Y, Farrell J, Pirmohamed M, Park BK, Naisbitt DJ. Generation and characterization of antigen-specific CD4+, CD8+, and CD4+CD8+ T-cell clones from patients with carbamazepine hypersensitivity. J. Allergy Clin. Immunol. 119(4), 973–981 (2007).
   PubMed Web of Science ®Google Scholar
• Rozieres A, Vocanson M, Rodet K et al. CD8+ T cells mediate skin allergy to amoxicillin in a mouse model. Allergy 65(8), 996–1003 (2010).
   PubMed Web of Science ®Google Scholar
• Mucida D, Cheroutre H. The many face-lifts of CD4 T helper cells. Adv. Immunol. 107, 139–152 (2010).
   PubMed Web of Science ®Google Scholar
• Oh S, Rankin AL, Caton AJ. CD4+CD25+ regulatory T cells in autoimmune arthritis. Immunol. Rev. 233(1), 97–111 (2010).
   PubMed Web of Science ®Google Scholar
• Soghoian DZ, Streeck H. Cytolytic CD4(+) T cells in viral immunity. Expert Rev. Vaccines 9(12), 1453–1463 (2010).
   PubMed Web of Science ®Google Scholar
• Naisbitt DJ, Farrell J, Wong G et al. Characterization of drug-specific T cells in lamotrigine hypersensitivity. J. Allergy Clin. Immunol. 111(6), 1393–1403 (2003).
   PubMed Web of Science ®Google Scholar
• Zawodniak A, Lochmatter P, Yerly D et al. In vitro detection of cytotoxic T and NK cells in peripheral blood of patients with various drug-induced skin diseases. Allergy 65(3), 376–384 (2010).
   PubMed Web of Science ®Google Scholar
• Wittmann M, Werfel T. Interaction of keratinocytes with infiltrating lymphocytes in allergic eczematous skin diseases. Curr. Opin. Allergy Clin. Immunol. 6(5), 329–334 (2006).
   PubMed Web of Science ®Google Scholar
• Chung WH, Hung SI, Yang JY et al. Granulysin is a key mediator for disseminated keratinocyte death in Stevens–Johnson syndrome and toxic epidermal necrolysis. Nat. Med. 14(12), 1343–1350 (2008).
   PubMed Web of Science ®Google Scholar
• Vivier E, Tomasello E, Baratin M, Walzer T, Ugolini S. Functions of natural killer cells. Nat. Immunol. 9(5), 503–510 (2008).
   PubMed Web of Science ®Google Scholar
• Vivier E. What is natural in natural killer cells? Immunol. Lett. 107(1), 1–7 (2006).
   PubMed Web of Science ®Google Scholar
• Ronchi F, Falcone M. Immune regulation by invariant NKT cells in autoimmunity. Front. Biosci. 13, 4827–4837 (2008).
   PubMed Web of Science ®Google Scholar
• Snyder-Cappione JE, Tincati C, Eccles-James IG et al. A comprehensive ex vivo functional analysis of human NKT cells reveals production of MIP1-a and MIP1-β, a lack of IL-17, and a Th1-bias in males. PLoS ONE 5(11), e15412 (2010).
   Web of Science ®Google Scholar
• Chaves P, Torres MJ, Aranda A et al. Natural killer-dendritic cell interaction in lymphocyte responses in hypersensitivity reactions to betalactams. Allergy 65(12), 1600–1608 (2010).
   PubMed Web of Science ®Google Scholar
• Morel E, Escamochero S, Cabañas R, Díaz R, Fiandor A, Bellón T. CD94/NKG2C is a killer effector molecule in patients with Stevens–Johnson syndrome and toxic epidermal necrolysis. J. Allergy Clin. Immunol. 125(3), 703–710, 710.e1 (2010).
   PubMed Web of Science ®Google Scholar
• Buckner JH. Mechanisms of impaired regulation by CD4(+)CD25(+)FOXP3(+) regulatory T cells in human autoimmune diseases. Nat. Rev. Immunol. 10(12), 849–859 (2010).
   PubMed Web of Science ®Google Scholar
• Shreffler WG, Wanich N, Moloney M, Nowak-Wegrzyn A, Sampson HA. Association of allergen-specific regulatory T cells with the onset of clinical tolerance to milk protein. J. Allergy Clin. Immunol. 123(1), 43–52.e7 (2009).
   PubMed Web of Science ®Google Scholar
• Takahashi R, Kano Y, Yamazaki Y, Kimishima M, Mizukawa Y, Shiohara T. Defective regulatory T cells in patients with severe drug eruptions: timing of the dysfunction is associated with the pathological phenotype and outcome. J. Immunol. 182(12), 8071–8079 (2009).
   PubMed Web of Science ®Google Scholar
• Pichler WJ, Naisbitt DJ, Park BK. Immune pathomechanism of drug hypersensitivity reactions. J. Allergy Clin. Immunol. 127(Suppl. 3), S74–S81 (2011).
   PubMed Web of Science ®Google Scholar
• Roth DB, Nakajima PB, Menetski JP, Bosma MJ, Gellert M. V(D)J recombination in mouse thymocytes: double-strand breaks near T cell receptor delta rearrangement signals. Cell 69(1), 41–53 (1992).
   PubMed Web of Science ®Google Scholar
• Turner SJ, Doherty PC, McCluskey J, Rossjohn J. Structural determinants of T-cell receptor bias in immunity. Nat. Rev. Immunol. 6(12), 883–894 (2006).
   PubMed Web of Science ®Google Scholar
• Davis MM, Boniface JJ, Reich Z et al. Ligand recognition by alpha beta T cell receptors. Annu. Rev. Immunol. 16, 523–544 (1998).
   PubMed Web of Science ®Google Scholar
• Arstila TP, Casrouge A, Baron V, Even J, Kanellopoulos J, Kourilsky P. A direct estimate of the human alphabeta T cell receptor diversity. Science 286(5441), 958–961 (1999).
   PubMed Web of Science ®Google Scholar
• Hermansson A, Ketelhuth DF, Strodthoff D et al. Inhibition of T cell response to native low-density lipoprotein reduces atherosclerosis. J. Exp. Med. 207(5), 1081–1093 (2010).
   PubMed Web of Science ®Google Scholar
• Hovhannisyan Z, Weiss A, Martin A et al. The role of HLA-DQ8 beta57 polymorphism in the anti-gluten T-cell response in coeliac disease. Nature 456(7221), 534–538 (2008).
   PubMed Web of Science ®Google Scholar
• Risitano AM, Maciejewski JP, Green S, Plasilova M, Zeng W, Young NS. In-vivo dominant immune responses in aplastic anaemia: molecular tracking of putatively pathogenetic T-cell clones by TCR beta-CDR3 sequencing. Lancet 364(9431), 355–364 (2004).
   PubMed Web of Science ®Google Scholar
• Padovan E, Casorati G, Dellabona P, Meyer S, Brockhaus M, Lanzavecchia A. Expression of two T cell receptor alpha chains: dual receptor T cells. Science 262(5132), 422–424 (1993).
   PubMed Web of Science ®Google Scholar
• Friese MA, Jakobsen KB, Friis L et al. Opposing effects of HLA class I molecules in tuning autoreactive CD8+ T cells in multiple sclerosis. Nat. Med. 14(11), 1227–1235 (2008).
   PubMed Web of Science ®Google Scholar
• Hwang HY, Bahk YY, Kim TG, Kim TY. Identification of a commonly used CDR3 region of infiltrating T cells expressing Vbeta13 and Vbeta15 derived from psoriasis patients. J. Invest. Dermatol. 120(3), 359–364 (2003).
   PubMed Web of Science ®Google Scholar
• Schwanninger A, Weinberger B, Weiskopf D et al. Age-related appearance of a CMV-specific high-avidity CD8+ T cell clonotype which does not occur in young adults. Immun. Ageing 5, 14 (2008).
   PubMedGoogle Scholar
• Flynn KJ, Belz GT, Altman JD, Ahmed R, Woodland DL, Doherty PC. Virus-specific CD8+ T cells in primary and secondary influenza pneumonia. Immunity 8(6), 683–691 (1998).
   PubMed Web of Science ®Google Scholar
• Mack CL, Falta MT, Sullivan AK et al. Oligoclonal expansions of CD4+ and CD8+ T-cells in the target organ of patients with biliary atresia. Gastroenterology 133(1), 278–287 (2007).
   PubMed Web of Science ®Google Scholar
• Reichardt P, Lehmann I, Sierig G, Borte M. Analysis of T-cell receptor V-beta 2 in peripheral blood lymphocytes as a diagnostic marker for Kawasaki disease. Infection 30(6), 360–364 (2002).
   PubMed Web of Science ®Google Scholar
• Menezes JS, van den Elzen P, Thornes J et al. A public T cell clonotype within a heterogeneous autoreactive repertoire is dominant in driving EAE. J. Clin. Invest. 117(8), 2176–2185 (2007).
   PubMed Web of Science ®Google Scholar
• Gras S, Chen Z, Miles JJ et al. Allelic polymorphism in the T cell receptor and its impact on immune responses. J. Exp. Med. 207(7), 1555–1567 (2010).
   PubMed Web of Science ®Google Scholar
• Hallmayer J, Faraco J, Lin L et al. Narcolepsy is strongly associated with the T-cell receptor alpha locus. Nat. Genet. 41(6), 708–711 (2009).
   PubMed Web of Science ®Google Scholar
• Pichler WJ, Zanni M, Von Greyerz S, Schnyder B, Mauri-Hellweg D, Wendland T. High IL-5 production by human drug-specific T cell clones. Int. Arch. Allergy Immunol. 113(1–3), 177–180 (1997).
   PubMed Web of Science ®Google Scholar
• Cederbrant K, Marcusson-Stâhl M, Hultman P. Characterization of primary recall in vitro lymphocyte responses to bacampicillin in allergic subjects. Clin. Exp. Allergy 30(10), 1450–1459 (2000).
   PubMed Web of Science ®Google Scholar
• Hashizume H, Takigawa M, Tokura Y. Characterization of drug-specific T cells in phenobarbital-induced eruption. J. Immunol. 168(10), 5359–5368 (2002).
   PubMed Web of Science ®Google Scholar
• Sieben S, Kawakubo Y, Al Masaoudi T, Merk HF, Blömeke B. Delayed-type hypersensitivity reaction to paraphenylenediamine is mediated by 2 different pathways of antigen recognition by specific alphabeta human T-cell clones. J. Allergy Clin. Immunol. 109(6), 1005–1011 (2002).
   PubMed Web of Science ®Google Scholar
• Ko TM, Chung WH, Wei CY et al. Shared and restricted T-cell receptor use is crucial for carbamazepine-induced Stevens–Johnson syndrome. J. Allergy Clin. Immunol. 128(6), 1266–1276.e11 (2011).
   PubMed Web of Science ®Google Scholar
• Hung SI, Chung WH, Jee SH et al. Genetic susceptibility to carbamazepine-induced cutaneous adverse drug reactions. Pharmacogenet. Genomics 16(4), 297–306 (2006).
   PubMed Web of Science ®Google Scholar
• Porebski G, Gschwend-Zawodniak A, Pichler WJ. In vitro diagnosis of T cell-mediated drug allergy. Clin. Exp. Allergy 41(4), 461–470 (2011).
   PubMed Web of Science ®Google Scholar
• Beeler A, Zaccaria L, Kawabata T, Gerber BO, Pichler WJ. CD69 upregulation on T cells as an in vitro marker for delayed-type drug hypersensitivity. Allergy 63(2), 181–188 (2008).
   PubMed Web of Science ®Google Scholar
• Leyva L, Torres MJ, Posadas S et al. Anticonvulsant-induced toxic epidermal necrolysis: monitoring the immunologic response. J. Allergy Clin. Immunol. 105(1 Pt 1), 157–165 (2000).
   PubMed Web of Science ®Google Scholar
• Caubet JC, Pichler WJ, Eigenmann PA. Educational case series: mechanisms of drug allergy. Pediatr. Allergy Immunol. 22(6), 559–567 (2011).
   PubMed Web of Science ®Google Scholar
• Pelikan Z. Delayed asthmatic response: a new phenotype of bronchial response to allergen challenge and soluble adhesion molecules in the serum. Ann. Allergy Asthma Immunol. 106(2), 119–130 (2011).
   PubMed Web of Science ®Google Scholar
• Ebbens FA, Toppila-Salmi SK, Renkonen JA et al. Endothelial L-selectin ligand expression in nasal polyps. Allergy 65(1), 95–102 (2010).
   PubMed Web of Science ®Google Scholar
• Devillier P. Comparing the new antihistamines: the role of pharmacological parameters. Clin. Exp. Allergy 36(1), 5–7 (2006).
   PubMed Web of Science ®Google Scholar
• Pichler WJ. Direct T-cell stimulations by drugs–bypassing the innate immune system. Toxicology 209(2), 95–100 (2005).
   PubMed Web of Science ®Google Scholar
• Swanson HI. Cytochrome P450 expression in human keratinocytes: an aryl hydrocarbon receptor perspective. Chem. Biol. Interact. 149(2–3), 69–79 (2004).
   PubMed Web of Science ®Google Scholar
• Roychowdhury S, Svensson CK. Mechanisms of drug-induced delayed-type hypersensitivity reactions in the skin. AAPS J. 7(4), E834–E846 (2005).
   PubMed Web of Science ®Google Scholar
• Gerber BO, Zanni MP, Uguccioni M et al. Functional expression of the eotaxin receptor CCR3 in T lymphocytes co-localizing with eosinophils. Curr. Biol. 7(11), 836–843 (1997).
   PubMed Web of Science ®Google Scholar
• Lochmatter P, Beeler A, Kawabata TT, Gerber BO, Pichler WJ. Drug-specific in vitro release of IL-2, IL-5, IL-13 and IFN-gamma in patients with delayed-type drug hypersensitivity. Allergy 64(9), 1269–1278 (2009).
   PubMed Web of Science ®Google Scholar
• Hausmann O, Schnyder B, Pichler WJ. Drug hypersensitivity reactions involving skin. Handb. Exp. Pharmacol. (196), 29–55 (2010).
   PubMedGoogle Scholar
• Vollmer J, Weltzien HU, Moulon C. TCR reactivity in human nickel allergy indicates contacts with complementarity-determining region 3 but excludes superantigen-like recognition. J. Immunol. 163(5), 2723–2731 (1999).
   PubMed Web of Science ®Google Scholar
• Büdinger L, Neuser N, Totzke U, Merk HF, Hertl M. Preferential usage of TCR-Vbeta17 by peripheral and cutaneous T cells in nickel-induced contact dermatitis. J. Immunol. 167(10), 6038–6044 (2001).
   PubMed Web of Science ®Google Scholar
• Vollmer J, Weltzien HU, Gamerdinger K, Lang S, Choleva Y, Moulon C. Antigen contacts by Ni-reactive TCR: typical alphass chain cooperation versus alpha chain-dominated specificity. Int. Immunol. 12(12), 1723–1731 (2000).
   PubMed Web of Science ®Google Scholar
• Popovic M, Shenton JM, Chen J et al. Nevirapine hypersensitivity. Handb. Exp. Pharmacol. (196), 437–451 (2010).
   PubMedGoogle Scholar
• Brander C, Mauri-Hellweg D, Bettens F, Rolli H, Goldman M, Pichler WJ. Heterogeneous T cell responses to beta-lactam-modified self-structures are observed in penicillin-allergic individuals. J. Immunol. 155(5), 2670–2678 (1995).
   PubMed Web of Science ®Google Scholar
• Mauri-Hellweg D, Bettens F, Mauri D, Brander C, Hunziker T, Pichler WJ. Activation of drug-specific CD4+ and CD8+ T cells in individuals allergic to sulfonamides, phenytoin, and carbamazepine. J. Immunol. 155(1), 462–472 (1995).
   PubMed Web of Science ®Google Scholar
• Burkhart C, Britschgi M, Strasser I et al. Non-covalent presentation of sulfamethoxazole to human CD4+ T cells is independent of distinct human leucocyte antigen-bound peptides. Clin. Exp. Allergy 32(11), 1635–1643 (2002).
   PubMedGoogle Scholar
• Price DA, Brenchley JM, Ruff LE et al. Avidity for antigen shapes clonal dominance in CD8+ T cell populations specific for persistent DNA viruses. J. Exp. Med. 202(10), 1349–1361 (2005).
   PubMed Web of Science ®Google Scholar
• Lawson TM, Man S, Williams S, Boon AC, Zambon M, Borysiewicz LK. Influenza A antigen exposure selects dominant Vbeta17+ TCR in human CD8+ cytotoxic T cell responses. Int. Immunol. 13(11), 1373–1381 (2001).
   PubMed Web of Science ®Google Scholar
• Oksenberg JR, Panzara MA, Begovich AB et al. Selection for T-cell receptor V beta-D beta-J beta gene rearrangements with specificity for a myelin basic protein peptide in brain lesions of multiple sclerosis. Nature 362(6415), 68–70 (1993).
   PubMed Web of Science ®Google Scholar